According to Clear Report, Huawei has filed a new patent that points to a method for diagnosing respiratory infections by measuring blood oxygen, or SpO2. This technology can detect the presence of a respiratory infection by detecting the level of oxygen in the blood. A summary of this patent specification provides its implementation with the detection method and associated hardware.
Various processes are included in Huawei’s test method. This method includes various steps such as testing the first process, responding to the first process, and sending it to the electronic device. The data of the physical parameters of the electronic device is received based on the raw data. When the physiological parameter information is determined to meet the preset conditions, it will receive audio information. Identification of the first physiological information based on the information of physiological parameters and acoustic information shows the first physiological information.
Blood oxygen saturation, breathing frequency, body temperature, heart rate, and other physiological parameters are examples of data used in aerobic technique. This method allows users to quickly detect the risk of infection in the respiratory tract and ensure that test results are accurate.
Currently, there are many smartwatches on the market that use sensors that detect oxygen levels in the blood, but they cannot rely on their own data. However, medical equipment is now available for accurate diagnosis.
It remains to be seen how Huawei’s final product will be with this company’s new strategy. Can this device provide reliable information or is it sold with a label “Do not use the information for medical purposes”. Of course, as always, Huawei’s new patent, like many patent certificates, never ends up producing the final product.
